Post Marketing Surveillance of Remicade in Inflammatory Bowel Disease (IBD).
Phase of Trial: Phase IV
Latest Information Update: 22 Jan 2013
At a glance
- Drugs Infliximab (Primary)
- Indications Ankylosing spondylitis; Crohn's disease
- Focus Adverse reactions
- Sponsors Schering-Plough
- 20 Jun 2012 Actual initiation date changed from May 2007 to Jun 2007 as reported by ClinicalTrials.gov.
- 20 Jun 2012 Actual patient number is 938 according to ClinicalTrials.gov.
- 20 Jun 2012 Actual end date (Aug 2011) added as reported by ClinicalTrials.gov.